LYNN MAINOLFI: Open Payments
NPI 1336226042 · WEXFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$999 in 55 payments from 8 companies in 2025. Trend: 2023 $604 · 2024 $520 · 2025 $999
Food & beverage: $999
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $319 |
| ABBVIE INC. | 14 | $179 |
| Axsome Therapeutics, Inc. | 11 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $123 |
| Janssen Pharmaceuticals, Inc | 1 | $114 |
| Lundbeck LLC | 3 | $69 |
| Corium, LLC | 5 | $30 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
Products named: REXULTI, VRAYLAR, Auvelity, CAPLYTA, INVEGA SUSTENNA, Azstarys, COBENFY.
Industry payments across PA — which companies pay providers there.
